Assignee
ENVIVO PHARMACEUTICALS INC
US·6 granted patents·21 pending applications·19 citations·filing 2004–2014
Top patents by PatentIndex Score
27 records- 0187US8343973B2Phenoxymethyl heterocyclic compoundsENVIVO PHARMACEUTICALS INC·Filed 2009·Granted Jan 1, 2013·7 cites·4 claims
- 0284US8815933B2Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereofENVIVO PHARMACEUTICALS INC·Filed 2014·Granted Aug 26, 2014·4 cites·13 claims
- 0383US9108961B2Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochlorideENVIVO PHARMACEUTICALS INC·Filed 2014·Granted Aug 18, 2015·5 cites·16 claims
- 0478US8569354B2Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereofENVIVO PHARMACEUTICALS INC·Filed 2012·Granted Oct 29, 2013·2 cites·26 claims
- 0574US8367863B2Tetrasubstituted benzenesENVIVO PHARMACEUTICALS INC·Filed 2012·Granted Feb 5, 2013·1 cites·12 claims
- 0670US2014148479A1Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts ThereofENVIVO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0763US2011040094A11,3,4-trisubstituted benzenesENVIVO PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0863US2015080325A1Methods for treating cognitive disorders using inhibitors of histone deacetylaseENVIVO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0961US2014364641A1Tetrasubstituted BenzenesENVIVO PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1059US8664249B2Tetrasubstituted benzenesENVIVO PHARMACEUTICALS INC·Filed 2013·Granted Mar 4, 2014·0 cites·33 claims
- 1158US2014187786A11,3,4-trisubstituted benzenesENVIVO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1254US2009202108A1Assaying and imaging system identifying traits of biological specimensENVIVO PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1352US2007037800A1Method of treating neurological disorders using clotrimazole and derivatives thereofENVIVO PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1451US2013317025A1Pde-10 inhibitorsENVIVO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1550US2005132425A1Transgenic flies expressing Abeta42-ItalianENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1649US2005108779A1Transgenic flies expressing Abeta42-ItalianENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1747US2005132421A1Transgenic flies expressing Abeta42-ArcticENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1847US2005132422A1Transgenic flies expressing Abeta42-IowaENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1947US2005132423A1Transgenic flies expressing Abeta42-FlemishENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2047US2005132424A1Transgenic flies expressing Abeta42-DutchENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2146US2004255342A1Transgenic flies expressing Abeta42-IowaENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2246US2004250302A1Transgenic flies expressing Abeta42-dutchENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2346US2004244064A1Transgenic flies expressing Abeta42-FlemishENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2446US2004255341A1Transgenic flies expressing Abeta42-ArcticENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2546US2006123489A1Sex-specific automated sorting of non-human animalsENVIVO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2642US2007281347A1Device and method for automated transfer of small organismsENVIVO PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2740US2014155429A1Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with NicotineENVIVO PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →